VivoSim Labs VIVS
NASDAQ VIVS
$0.26 0.00 (-0.27%)
As of: Sep 17, 2026 · 3:59 PM EDT

VivoSim Labs (VIVS) Gross Profit (2011 - 2026)

VivoSim Labs (VIVS) posted Gross Profit of $40000.0 for Q1 2026, up 53.85% on a QoQ basis from $26000.0 in Q4 2025, and down 21.57% year-over-year from $51000.0 in Q1 2025.

Analysis

VivoSim Labs (VIVS) Gross Profit (2011 - 2026) Analysis & Trends

VivoSim Labs has reported Gross Profit for 10 years, with the latest figure at $40000.0 in Q1 2026.

  • On a quarterly basis, Gross Profit fell 21.57% year-over-year to $40000.0 in Q1 2026; TTM through Mar 2026 was $131000.0, a 5.76% decrease from a year earlier, with the FY2026 full-year figure at $131000.0, down 5.76% from the prior year.
  • Gross Profit was $40000.0 for Q1 2026 at VivoSim Labs, up from $26000.0 in the prior quarter.
  • The five-year high for Gross Profit was $75000.0 in Q2 2023, with the low at $5000.0 in Q4 2023.
  • Average Gross Profit over 4 years is $34454.5, with a median of $29000.0 recorded in 2024.
  • The largest YoY upside for Gross Profit was 340.0% in 2024 against a maximum downside of 50.67% in 2024.
  • Over 4 years, Gross Profit stood at $5000.0 in 2023, then surged by 340.0% to $22000.0 in 2024, then rose by 18.18% to $26000.0 in 2025, then surged by 53.85% to $40000.0 in 2026.
  • The last three Gross Profit figures came in at $40000.0 (Q1 2026), $26000.0 (Q4 2025), and $28000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 40,000.00
Dec 31, 2025 26,000.00
Sep 30, 2025 28,000.00
Jun 30, 2025 37,000.00
Mar 31, 2025 51,000.00
Dec 31, 2024 22,000.00
Sep 30, 2024 29,000.00
Jun 30, 2024 37,000.00
Mar 31, 2024 29,000.00
Dec 31, 2023 5,000.00
Jun 30, 2023 75,000.00
Dec 31, 2019 285,000.00
Sep 30, 2019 966,000.00
Jun 30, 2019 617,000.00
Mar 31, 2019 579,000.00
Dec 31, 2018 643,000.00
Sep 30, 2018 818,000.00
Jun 30, 2018 569,000.00
Mar 31, 2018 822,000.00
Dec 31, 2017 961,000.00